You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

28 June 2017

HIV wonder drug dolutegravir to be rolled-out in Kenya

UNITAID partners to bring newer and more effective HIV treatment options to countries where they are needed most.

0
22 June 2017

PrEP now included on the WHO Essential Medicines List

Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir.

0
03 May 2017

India to provide free treatment for all people living with HIV

The country with the third largest HIV epidemic moves to a test-and-treat strategy that aims to get everyone on antiretroviral therapy.

0
16 March 2017

Nanomedicine could reduce dose and cost of treatment for people living with HIV, early trials show

The first trials enhancing orally-taken antiretroviral treatment with Solid Drug Nanoparticle technology have produced “incredibly promising” results.

0
03 March 2017

Decentralised antiretroviral treatment delivery in an urban setting – a Kinshasa success

The first ever study evaluating the decentralising of HIV care through antiretroviral treatment (ART) distribution centres shows low rates of patient loss in the city.

0
21 February 2017

Pre-treatment drug resistance as high as 17% with no impact on viral load suppression

‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.

0
14 February 2017

HIV self-testing a useful tool for pre-exposure prophylaxis (PrEP) delivery in Kenya

Mixed-status couples using PrEP could benefit from HIV self-testing as a way to quickly diagnose any new infections and reduce frequency of clinic visits.

0
10 February 2017

Lack of female head of household and distance to clinic linked to loss to follow-up in Malawi

Identifying individuals at high risk of disengaging with HIV care remains an important strategy for realising the benefits of antiretroviral treatment for public health.

0
19 January 2017

Rural and urban patterns of HIV drug resistance in South Africa

HIV is more proactively monitored among urban HIV patients than rural patients, and drug resistance and treatment failure is less prevalent. However outcomes for second line treatment remain similar.

0
11 January 2017

Interventions to keep people in HIV care more cost-effective than a ‘treat all’ approach

Treatment scale-up has had major public health benefits. But where resources are scarce, interventions to keep people in care could be more cost-effective than moving to treat everybody living with HIV after diagnosis.

0